Soteria Biotherapeutics is a biotechnology company developing cancer immunotherapies that is headquartered in San Francisco, California and was founded in 2018 by Alexander Martinko and Zachary Hill.
Soteria Biotherapeutics is developing t-cells that are conditioned to engage antibodies to treat solid tumor cancers. Their platform T-LITETM, offers small molecule-dependent activation of bispecific antibody therapies. The platform is designed to enable treatments through pulsatile activity, and reduce side effects.
The platform incorporates a small molecule-controlled switch to carry out its use and T-cell cytotoxic activity. The platform creates the activity of immunomodulatory therapeutics such as bi-specific T-Cell engagers, and CAR T-cells. Soteria Biotherapeutics offers services in order to develop their protein switches.
Timeline
SBA Awards
People
Alexander Martinko
Co-Founder
Zachary Hill
Co-Founder
Further reading
Soteria Biotherapeutics Company Profile: Valuation & Investors | PitchBook
Web
Soteria Biotherapeutics Company Profile: Valuation & Investors | PitchBook
Web
Documentaries, videos and podcasts
Soteria Therapeutics Pitch Example | UCSF Entrepreneurship Center Startup 101
May 15, 2018
Companies
Soteria Biotherapeutics
San Francisco, California, United States
Biotherapeutics